Effectively delivering pharmaceutical aerosols to the lungs of preterm and term infants represents a considerable technical challenge. The purpose of the work reported in this article was to report the use of modeling to develop an understanding of the regional deposition of aerosols in neonates and to build a theoretical basis for choosing an optimum aerosol size to maximize delivery and minimize variability.
